Pricing Log in Create free account

Abeona Therapeutics Inc. (ABEO) vs Vanda Pharmaceuticals Inc. (VNDA)

Abeona Therapeutics Inc. and Vanda Pharmaceuticals Inc. are both Biotechnology companies. Abeona Therapeutics Inc. and Vanda Pharmaceuticals Inc. are of similar size ($265.9M and $256.4M). Abeona Therapeutics Inc. grew revenue faster over the last twelve months: 427.5% against 6.02%. Vanda Pharmaceuticals Inc. has the higher net margin (−127.4% vs −242.6%) and the lower return on invested capital (−217.6% vs 0.00%). Across the 18 metrics below, Abeona Therapeutics Inc. leads on 9 and Vanda Pharmaceuticals Inc. on 9.

Valuation

Metric ABEO VNDA Biotechnology median
P/E n/m n/m 8.50
P/S 9.68 1.13 9.71
P/B 1.96 1.10 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 4.60 0.35 9.21
Earnings yield (26.59%) (114.89%) (33.15%)
Free cash flow yield (32.48%) (63.04%) (25.50%)

Profitability

Metric ABEO VNDA Biotechnology median
Gross margin 66.03% 93.74% 65.16%
Operating margin (322.59%) (86.07%) 0.00%
Net margin (242.62%) (127.41%) 0.00%
Free cash flow margin (314.53%) (70.93%) 0.00%
Return on equity (43.13%) (77.81%) (56.36%)
Return on assets (29.54%) (53.00%) (48.04%)
Return on invested capital 0.00% (217.59%) 0.00%

Growth

Metric ABEO VNDA Biotechnology median
Revenue growth (TTM) 427.47% 6.02% 6.02%
EPS growth (last fiscal year) 165.16% (1,033.33%) 30.26%
Revenue growth, 5-year CAGR 14.19% (2.73%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABEO VNDA Biotechnology median
Debt to equity 0.12 0.01 0.00
Current ratio 6.63 1.61 4.72
Net debt to EBITDA 2.00 1.84 0.96

Dividend

Metric ABEO VNDA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABEO VNDA Biotechnology median
Market cap 265.90m 256.36m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack